膀胱腫瘍再発予防に関する研究 : 第1報尿中β-Gluculonidase活性阻害剤2,5-di-o-acetyl, D-glucaro (1-4)(6-3) dilactone投与による膀胱腫瘍再発抑制に関する臨床的,実験的研究 : 特に長期投与例を中心として

概要

論文の詳細を見る
I applied β-glucuronidase (β-G) inhibitor in urine, 2,5-di-o-acetyl, D-glucaro (1-4)(6-3) dilactone (SLA), which was produced on Boyland's hypothesis, for the purpose of preventing recurrence after operation of bladder tumor. Comparing the group of forty-four cases given SLA in low grade and low stage with another group of fifty-two cases not given SLA, I examined the rate of recurrence by analyzing the various factors, the fluctuation of β-G activity and the amount of glucaricacric in urine by using SLA in bladder tumor patients before and after operation: I also examined the relationships between β-G activity and o-glucuronide.
社団法人日本泌尿器科学会の論文
1972-11-20